Pharmacogenomic Services
|
 |
Translational Research
& Clinical Trial Support
Utilizing the Most
Sensitive Mutation Detection Technology
to Support Translational and Clinical Research
 |
As a leader in the development of novel technologies and
solutions for companies around the world, Pharmacogenomic Services supports
translational and clinical research with the most sensitive technology in mutation
detection available in the following areas:
FROM PRE-CLINICAL TO PHASE III, WE ARE YOUR PARTNER
| Early Screening |
Patient Stratification |
Assessment of Drug Resistance |
| Therapeutic Toxicity |
Disease Modeling |
Biomarker Discovery and Validation |
| Detection of Metastatic Events |
Residual Disease Monitoring |
Pharmacogenomic Interaction |
TRANSLATIONAL RESEARCH
Bringing your projects to fruition and to market is our priority. Whether your
projects stem from pharmacogenomics to biomarker discovery or from cancer
research to inherited disease, Transgenomic can help you in all stages of development from concept to launch.
For questions or to discuss a new project,
contact our professionals at 240-631-2001.
|